This protein is expressed on phagocytic cells that interact with CD47-bearing EVs, inhibiting CD47 on cancer cells and thereby increasing cancer cell phagocytosis and inducing anti-tumour T cell responses [346,347,348,349]. This evidence concerns the gene CD47 and neoplasm.